- Virus-host interactions
- Structure and function of retroviral integrase
- Allosteric inhibitors of HIV-1 integrase
Dr. Kvaratskhelia’s research focuses on elucidating the molecular mechanisms for retroviral integration into the host genome, dissecting virus-host interactions, discovery of HIV-1 integrase inhibitors with allosteric mechanisms of action and developing retroviral vectors for human gene-therapy. His laboratory employs innovative and complementary biochemical, biophysical, structural biology, molecular biology and virology approaches.
After obtaining MS and PhD degrees in the former USSR, Dr. Kvaratskhelia received postdoctoral training with Dr. Roger Thorneley at the Department of Biological Chemistry, John Innes Center, England, UK (1995-1998) and with Dr. Malcolm White at the Department of Biochemistry, University of Dundee, Scotland, UK (1998-2000). Dr. Kvaratskhelia then worked as a Research Fellow in Dr. Stuart Le Grice’s laboratory (2000-2003) at HIV Drug Resistance Program, National Cancer Institute, Frederick, MD, USA before joining the Ohio State University College of Pharmacy and Center for Retrovirus Research in 2003 as a faculty member.
- 2016: Kimberly Professorship, The Ohio State University College of Pharmacy.
- 2007: Research Career Development Award, NIH/NIAID.
- Eur J Med Chem. 2016 Nov 10;123:673-83
- ACS Infect Dis. 2016 Oct 5;
- J Biol Chem. 2016 Sep 19;:
- Sci Rep. 2016 Sep 01;6:32499
- Cell. Cell. 2016 Aug 25;166(5):1257-1268.e12
- Protein Sci. 2016 Aug 9;:
- Nucleic Acids Res. 2016 Jun 20;44(11):5344-55
- ACS Chem Biol. 2016 Mar 2;
- Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2086-91
- J Biol Chem. 2014 Sep 19;289(38):26430-40